2011
DOI: 10.1093/ndtplus/4.s2.42
|View full text |Cite
|
Sign up to set email alerts
|

Transplantation: basic science and immune-tolerance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2017
2017

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…They observed that a richer ECM protein and growth factor content were present in the Triton-treated scaffold than in the SDS-treated scaffold; additionally, cell viability, adherence, and proliferation were higher with the Triton-treated scaffold than with the SDS-treated scaffold (Choi et al, 2015 ). Furthermore, other researchers have demonstrated that the combination of the two agents produces better results (Sugawara et al, 2011 ). In view of these divergences, there is still a need to identify more suitable decellularizing agents to improve the quality of the obtained scaffolds (Table 1 ) (Ross et al, 2009 , 2012 ; Peloso et al, 2013 ; Song et al, 2013 ).…”
Section: Methods and Processes Applied For Organ Decellularizationmentioning
confidence: 97%
“…They observed that a richer ECM protein and growth factor content were present in the Triton-treated scaffold than in the SDS-treated scaffold; additionally, cell viability, adherence, and proliferation were higher with the Triton-treated scaffold than with the SDS-treated scaffold (Choi et al, 2015 ). Furthermore, other researchers have demonstrated that the combination of the two agents produces better results (Sugawara et al, 2011 ). In view of these divergences, there is still a need to identify more suitable decellularizing agents to improve the quality of the obtained scaffolds (Table 1 ) (Ross et al, 2009 , 2012 ; Peloso et al, 2013 ; Song et al, 2013 ).…”
Section: Methods and Processes Applied For Organ Decellularizationmentioning
confidence: 97%